🔗 Share this article

The top legal official in Texas Paxton is taking legal action against the producers of acetaminophen, claiming the companies hid alleged dangers that the medication posed to pediatric neurological development.

The court filing follows four weeks after President Donald Trump promoted an unverified association between consuming Tylenol - referred to as paracetamol - during pregnancy and autism spectrum disorder in offspring.

Paxton is taking legal action against the pharmaceutical giant, which formerly manufactured the drug, the sole analgesic recommended for pregnant women, and the current manufacturer, which presently makes it.

In a official comment, he claimed they "misled consumers by making money from discomfort and marketing drugs ignoring the risks."

Kenvue asserts there is insufficient reliable data connecting Tylenol to autism.

"These companies deceived for years, intentionally threatening millions to line their pockets," the attorney general, a Republican, said.

The manufacturer commented that it was "deeply concerned by the dissemination of inaccurate information on the security of paracetamol and the likely effects that could have on the welfare of American women and children."

On its online platform, Kenvue also stated it had "regularly reviewed the relevant science and there is no credible data that demonstrates a established connection between using paracetamol and autism spectrum disorder."

Associations representing medical professionals and medical practitioners share this view.

ACOG has said paracetamol - the primary component in acetaminophen - is a restricted selection for women during pregnancy to manage discomfort and fever, which can pose serious health risks if left untreated.

"In more than two decades of investigation on the use of paracetamol in pregnancy, no reliable research has successfully concluded that the consumption of acetaminophen in any trimester of gestation results in neurodevelopmental disorders in offspring," the association said.

This legal action mentions current declarations from the former administration in claiming the drug is potentially dangerous.

Last month, the former president generated worry from public health officials when he advised pregnant women to "fight like hell" not to consume Tylenol when ill.

The FDA then released a statement that medical professionals should contemplate reducing the consumption of Tylenol, while also mentioning that "a proven link" between the medication and autism spectrum disorder in children has not been proven.

The Health Department head Kennedy, who oversees the Food and Drug Administration, had pledged in April to undertake "extensive scientific investigation" that would determine the origin of autism spectrum disorder in a limited time.

But specialists advised that discovering a sole reason of autism spectrum disorder - considered by experts to be the outcome of a intricate combination of genetic and external influences - would not be simple.

Autism spectrum disorder is a type of lifelong neurodivergence and disability that affects how individuals experience and relate to the surroundings, and is recognized using medical professional evaluations.

In his lawsuit, the attorney general - who supports Trump who is campaigning for US Senate - claims the manufacturer and Johnson & Johnson "deliberately disregarded and tried to quiet the evidence" around acetaminophen and autism.

The lawsuit aims to force the companies "remove any marketing or advertising" that asserts acetaminophen is safe for pregnant women.

The Texas lawsuit echoes the complaints of a assembly of guardians of young ones with autism and attention deficit hyperactivity disorder who filed suit against the manufacturers of acetaminophen in two years ago.

The court threw out the case, saying investigations from the family's specialists was inconclusive.